Increased expressions of ST3GAL4 (82), ST6GAL1 (80), and ST6GalNAc1 (81) were identified in most patients with NSCLC, and inhibiting these enzymes may suppress NSCLC cell metastasis. The gene discussed is ST3GAL4; the disease is non-small cell lung carcinoma.